tm logo
SUNOVION
Live/Registered
REGISTERED AND RENEWED

on 08 Jul 2022

Last Applicant/ Owned by

OSAKA-SHI

OSAKA

JP

541-0045

Serial Number

77883223 filed on 01st Dec 2009

Registration Number

4096601 registered on 07th Feb 2012

in the Principal Register

Correspondent Address

Kumiko Ide

Kumiko Ide

1025 Connecticut Avenue NW, Suite 500

Washington DC 20036

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

SUNOVION

Pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the central nervous, peripheral nervous and respiratory systems; pharmaceutical preparations for the prevention and treatment of sleep disorders

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the central nervous, peripheral nervous and respiratory systems; pharmaceutical preparations for the prevention and treatment of sleep disorders


First Use Date in General

06th Jan 2011

First Use Date in Commerce

06th Jan 2011

Mark Details


Serial Number

No 77883223

Mark Type

No Service/Collective Mark

Attorney Docket Number

No TM09-179

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
08th Jul 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08th Jul 2022REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08th Jul 2022REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08th Jul 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01st Feb 2022TEAS SECTION 8 & 9 RECEIVED
07th Feb 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01st Sep 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
01st Sep 2017REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
31st Aug 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
26th Jul 2017TEAS SECTION 8 & 15 RECEIVED